Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

NCT06471231 is registered in ClinicalTrials.gov with Azienda Usl di Bologna as lead sponsor.

NCT NCT06471231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06471231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock
Lead sponsor
Azienda Usl di Bologna
Phase
Phase 4
Overall status
Unknown status
Start date
May 15, 2024
Completion date
May 15, 2026
Enrollment
264 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal function replacement, septic shock